APOE ε3 gene transfer attenuates brain damage after experimental stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 27, Issue 3, 2007, Pages 477-487

  McColl, Barry W ^a,f   McGregor, Ailsa L ^b,g   Wong, Andrew ^b   Harris, Julian D ^c   Amalfitano, Andrea ^d   Magnoni, Sandra ^b   Baker, Andrew H ^e   Dickson, George ^c   Horsburgh, Karen ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Adenovirus; Apolipoprotein E; Cerebral ischaemia; Gene therapy; Neuroprotection

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN E3; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOLIPOPROTEIN E3 GENE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; GENE; GENE TRANSFER; IMMUNOREACTIVITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STROKE; TREATMENT OUTCOME; WHITE MATTER; ADENOVIRUS; ANIMAL; BRAIN; CEREBROVASCULAR ACCIDENT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEIN E3; BRAIN; CEREBROVASCULAR ACCIDENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE;

EID: 33847224449     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600361     Document Type: Article

References (48)

1. Abe K, Setoguchi Y, Hayashi T, Itoyama Y (1997) In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brain. Brain Res 763:191-201
2. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD (1995) ApoE genotype and survival from intracerebral haemorrhage. Lancet 346:575
3. Amalfitano A, Chamberlain JS (1997) Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy. Gene Ther 4:258-63
4. Amalfitano A, Hauser MA, Hu H, Serra D, Begy CR, Chamberlain JS (1998) Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol 72:926-33
5. Aoki K, Uchihara T, Sanjo N, Nakamura A, Ikeda K, Tsuchiya K, Wakayama Y (2003) Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke 34:875-80
6. Aono M, Lee Y, Grant ER, Zivin RA, Pearlstein RD, Warner DS, Bennett ER, Laskowitz DT (2002) Apolipoprotein E protects against NMDA excitotoxicity. Neurobiol Dis 11:214-20
7. Bacskai BJ, Xia MQ, Strickland DK, Rebeck GW, Hyman BT (2000) The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 97:11551-6
8. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-6
9. Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res 33:174-8
10. Betz AL, Yang GY, Davidson BL (1995) Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab 15:547-51
11. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci 19:4867-80
12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-3
13. DeKroon RM, Mihovilovic M, Goodger ZV, Robinette JB, Sullivan PM, Saunders AM, Strittmatter WJ (2003) ApoE genotype-specific inhibition of apoptosis. J Lipid Res 44:1566-73
14. Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GV (1996) Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp Neurol 138:252-60
15. Glover CP, Bienemann AS, Heywood DJ, Cosgrave AS, Uney JB (2002) Adenoviral-mediated, high-level, cell-specific transgene expression: a SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity. Mol Ther 5:509-16
16. Harris JD, Graham IR, Schepelmann S, Stannard AK, Roberts ML, Hodges BL, Hill V, Amalfitano A, Hassall DG, Owen JS, Dickson G (2002) Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE. Hum Mol Genet 11:43-58
17. Hermann DM, Kilic E, Kugler S, Isenmann S, Bahr M (2001) Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis 8:655-66
18. Horsburgh K, Nicoll JA (1996) Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat. Neuropathol Appl Neurobiol 22:342-9
19. Horsburgh K, Graham DI, Stewart J, Nicoll JA (1999) Influence of apolipoprotein E genotype on neuronal damage and apoE imunoreactivity in human hippocampus following global ischemia. J Neuropathol Exp Neurol 58:227-34
20. Horsburgh K, McCarron MO, White F, Nicoll JA (2000a) The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 21:245-55
21. Horsburgh K, McCulloch J, Nilsen M, McCracken E, Large C, Roses AD, Nicoll JA (2000b) Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice. J Cereb Blood Flow Metab 20:458-62
22. Horsburgh K, McCulloch J, Nilsen M, Roses AD, Nicoll JA (2000c) Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. Eur J Neurosci 12:4309-17
23. Kitagawa H, Sasaki C, Sakai K, Mori A, Mitsumoto Y, Mori T, Fukuchi Y, Setoguchi Y, Abe K (1999) Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 19:1336-44
24. Kugler S, Meyn L, Holzmuller H, Gerhardt E, Isenmann S, Schulz JB, Bahr M (2001) Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci 17:78-96
25. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS (1997) Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 17:753-8
26. Loser P, Jennings GS, Strauss M, Sandig V (1998) Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol 72:180-90
27. Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT (2003) APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 278:48529-33
28. Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T (1997) Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res 751:307-14
29. McAdoo JD,Warner DS, Goldberg RN, Vitek MP, Pearlstein R, Laskowitz DT (2005) Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury. Neurosci Lett 381:305-8
30. McColl BW, Carswell HV, McCulloch J, Horsburgh K (2004) Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Res 997:15-23
31. Ooboshi H, Ibayashi S, Takada J, Kumai Y, Iida M (2003) Brain ischemia as a potential target of gene therapy. Exp Gerontol 38:183-7
32. Panza F, Solfrizzi V, Colacicco AM, Basile AM, D'Introno A, Capurso C, Sabba M, Capurso S, Capurso A (2003) Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians. Neuroreport 14:605-8
33. Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17:525-30
34. Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, Kafatos A, Martins MC, Sans S, Sass C, Visvikis S, De Backer G, Siest G (2000) Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atheroclerosis 152:475-788
35. Sheng H, Laskowitz DT, Mackensen GB, Kudo M, Pearlstein RD, Warner DS (1999) Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke 30:1118-24
36. Speir E, Shibutani T, Yu ZX, Ferrans V, Epstein SE (1996) Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 79:1143-52
37. Strittmatter WJ, Bova HC (2002) Molecular biology of apolipoprotein E. Curr Opin Lipidol 13:119-23
38. Teasdale GM, Nicoll JA, Murray G, Fiddes M (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350:1069-71
39. Thilmann R, Xie Y, Kleihues P, Kiessling M (1986) Persistent inhibition of protein synthesis precedes neuronal death in postischemic gerbil hippocampus. Acta Neuropathol (Berl) 71:88-93
40. Thomas CE, Schiedner G, Kochanek S, Castro MG, Lowenstein PR (2000) Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. Proc Natl Acad Sci USA 97:7482-7
41. Vance JE, Campenot RB, Vance DE (2000) The synthesis and transport of lipids for axonal growth and nerve regeneration. Biochim Biophys Acta 1486:84-96
42. Weisgraber KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249-302
43. Wheeler MD, Kono H, Rusyn I, Arteel GE, McCarty D, Samulski RJ, Thurman RG (2000) Chronic ethanol increases adeno-associated viral transgene expression in rat liver via oxidant and NFkappaB-dependent mechanisms. Hepatology 32:1050-9
44. Wood MJ, Charlton HM, Wood KJ, Kajiwara K, Byrnes AP (1996) Immune responses to adenovirus vectors in the nervous system. Trends Neurosci 19:497-501
45. Yenari MA, Minami M, Sun GH, Meier TJ, Kunis DM, McLaughlin JR, Ho DY, Sapolsky RM, Steinberg GK (2001) Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 32:1028-35
46. Zhang WR, Sato K, Iwai M, Nagano I, Manabe Y, Abe K (2002) Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat. Brain Res 947:140-5
47. Zhao H, Yenari MA, Cheng D, Sapolsky RM, Steinberg GK (2003) Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 85:1026-36
48. Zou L, Zhou H, Pastore L, Yang K (2000) Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system. Mol Ther 2:105-13